Regional Health Properties,Inc. | REIT Profile
Symbol: RHE
CIK: 1697416
Exchange: NYSE
Founded: 1991 (34 years)
HQ: Scottsdale, AZ, United States
Type of REIT: Equity REIT
Listing Status: Public
Market Capitalization: Micro-Cap
REIT Sector: Health Care
Internally Managed REIT
REITRating™ Score: 2.1
See RHE on Yahoo Finance
See RHE on SEC.gov
 |
 |
Founded in 1991, Regional Health Properties, Inc. | NYSE American: RHE) is a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. The company currently owns, leases or manages for third parties.
Stock Chart
REITRating™ Trend
REITRating™ is REITNotes' Real Estate Investment Trust industry-specific rating and ranking system. The overall score is out of ten points, with ten being the best score. The graph below plots the overall REITRating™ score for the last 14 months. See the score breakdown | Compare with other REITs | See the complete trend
Latest REIT Press Releases
- Regional Health Properties, Inc. and SunLink Health Systems, Inc. Announce Receipt of Shareholder Approvals for Merger - Tue, 4 Aug 2025 20:26:18 UTC
- Regional Health Properties, Inc. Announces Special Meeting Results and Termination of Exchange Offer - Mon, 25 Jul 2022 17:31:08 -0400 (EDT)
- Regional Health Properties, Inc. Reminds Common Shareholders of Upcoming Special Meeting and Encourages Common Shareholders to Vote - Mon, 18 Jul 2022 10:03:29 -0400 (EDT)
- Regional Health Properties, Inc. Announces Convening and Adjournment of Special Meeting, Information for Reconvened Special Meeting and Extension of Exchange Offer - Wed, 1 Jun 2022 08:22:04 -0400 (EDT)
- Regional Health Properties, Inc. Announces Convening and Adjournment of Special Meeting, Information for Reconvened Special Meeting and Extension of Exchange Offer - Tue, 3 May 2022 08:32:02 -0400 (EDT)
Key Stats of Trading Day 2025-02-28
EBITDA: $1,760,000 [?]
P/E (Price-to-Earnings) Ratio: N/A [?]
PEG (Price/Earnings to Growth) Ratio: N/A [?]
Book Value: -10.71 [?]
Dividend Per Share (DPS): N/A [?]
Earnings Per Share (EPS): -1.55 [?]
Revenue Per Share (TTM): $8.56 [?]
Profit Margin: -18.10% [?]
Operating Margin (TTM): 5.00% [?]
Return on Equity (TTM): -534.00% [?]
Revenue (TTM): $15,936,000 [?]
Gross Profit (TTM): $6,434,000 [?]
Diluted EPS (TTM): $-1.55 [?]
Quarterly Earnings Growth YOY: N/A [?]
Quarterly Revenue Growth YOY: -6.20% [?]
Trailing P/E: N/A [?]
Forward P/E: N/A [?]
Beta: 0.95 [?]
Price-to-Book (P/B): N/A [?]
Enterprise Value (EV) to Revenue: 4.07 [?]
EV to EBITDA: 38.20x [?]
Shares Outstanding: 1,879,200 [?]
52 Week High: $3.56 [?]
52 Week Low: $1.13 [?]
50 Day Moving Average: $1.96 [?]
200 Day Moving Average: $1.99 [?]
REIT Simulation
Below is a simulation of how much money you would have made in dividends, and how much the shares would be worth had you purchased them 1 year ago for the amounts below.
| With $1,000 USD | With $500 USD | With $250 USD | With $100 USD | With $50 USD | |
|---|---|---|---|---|---|
| Initial investment | @ $1.51 per share you would have been able to buy 662 shares of RHE on 2024-12-14 costing $999.62 | @ $1.51 per share you would have been able to buy 331 shares of RHE on 2024-12-14 costing $499.81 | @ $1.51 per share you would have been able to buy 165 shares of RHE on 2024-12-14 costing $249.15 | @ $1.51 per share you would have been able to buy 66 shares of RHE on 2024-12-14 costing $99.66 | @ $1.51 per share you would have been able to buy 33 shares of RHE on 2024-12-14 costing $49.83 |
| Current worth | On 2025-02-05 these 662 shares would be worth $1,836.39 @ $2.77 | On 2025-02-05 these 331 shares would be worth $918.19 @ $2.77 | On 2025-02-05 these 165 shares would be worth $457.71 @ $2.77 | On 2025-02-05 these 66 shares would be worth $183.08 @ $2.77 | On 2025-02-05 these 33 shares would be worth $91.54 @ $2.77 |
| Dividends earned | $0.00 in dividends would have been earned since 2024-12-14 with 662 shares. | $0 in dividends would have been earned since 2024-12-14 with 331 shares. | $0.00 in dividends would have been earned since 2024-12-14 with 165 shares. | $0.00 in dividends would have been earned since 2024-12-14 with 66 shares. | $0.00 in dividends would have been earned since 2024-12-14 with 331 shares. |
| Net (gain / loss)* | 836.77 USD | 418.38 USD | 208.56 USD | 83.42 USD | 41.71 USD |
| ROI** | 83.71% | 83.71% | 83.71% | 83.71% | 83.71% |
*Net (Gains/Loss): Includes the stock price (appreciate or depreciate ) + dividends earned during period held. Stock prices based on closing price for the date. **ROI: Is based on the Net (gain/loss) divided by the initial investment value. Note: Past performance is no guarantee of future results. This is a high-level simulation and does not account for many factors such as inflation and taxes so we cannot guarantee the accuracy of this simulation.
Related REITs
| REIT | REITRating™ Score | Exchange | Market Capitalization | Sector | Country |
|---|---|---|---|---|---|
| Gyrodyne Company of America, Inc. (GYRO) | N/A | NASDAQ | Micro-Cap | Industrial Office Health Care Diversified | United States |
| Selectis Health Inc (GBCS) | 0.3 | OTCMKTS | Micro-Cap | Health Care | United States |
Last updated: 2025-12-14 - v7.0